Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.

@article{Findling2013EfficacyLS,
  title={Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.},
  author={Robert L. Findling and Idil Cavus and Elizabeth A Pappadopulos and Douglas G Vanderburg and Jeffrey H Schwartz and Balarama K Gundapaneni and Melissa P. Delbello},
  journal={Journal of child and adolescent psychopharmacology},
  year={2013},
  volume={23 8},
  pages={545-57}
}
OBJECTIVE The purpose of this study was to evaluate the short- and long-term efficacy and safety of ziprasidone in children and adolescents with bipolar I disorder. METHODS Subjects 10-17 years of age with a manic or mixed episode associated with bipolar I disorder participated in a 4 week, randomized, double-blind, placebo-controlled multicenter trial (RCT) followed by a 26 week open-label extension study (OLE). Subjects were randomized 2:1 to initially receive flexible-dose ziprasidone (40… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS
7 Citations
40 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 40 references

Children’s Depression Rating Scale, Revised Manual

  • EO Poznanski, HB Mokros
  • Los Angeles: Western Psychological Services;
  • 1996
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…